Ludovic Leloup

Marseille, 13005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential.

Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential.

Journal: Medical sciences (Basel, Switzerland)

Published: February 10, 2026

Bifunctional Metformin-Phenolic Hybrids with Improved Anticancer and Antioxidant Properties: Evaluation on Glioma Cells.

Bifunctional Metformin-Phenolic Hybrids with Improved Anticancer and Antioxidant Properties: Evaluation on Glioma Cells.

Journal: International journal of molecular sciences

Published: December 18, 2025

C-Phycocyanin-Cisplatin Combination Targeting Redox Balance for Enhanced Efficacy Against Glioblastoma Cells.

C-Phycocyanin-Cisplatin Combination Targeting Redox Balance for Enhanced Efficacy Against Glioblastoma Cells.

Journal: Oncology research

Published: July 22, 2025

Pathological Impact of Redox Post-Translational Modifications.

Pathological Impact of Redox Post-Translational Modifications.

Journal: Antioxidants & redox signaling

Published: March 20, 2024

Overexpression of a Novel Noxo1 Mutant Increases Ros Production and Noxo1 Relocalisation.

Overexpression of a Novel Noxo1 Mutant Increases Ros Production and Noxo1 Relocalisation.

Journal: International journal of molecular sciences

Published: December 06, 2022

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer.

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer.

Journal: Cancers

Published: October 09, 2022

The NADPH Oxidase Family and Its Inhibitors.

The NADPH Oxidase Family and Its Inhibitors.

Journal: Antioxidants & redox signaling

Published: December 13, 2019

Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.

Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.

Journal: Oncotarget

Published: June 22, 2018

Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.

Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.

Journal: Oncotarget

Published: July 21, 2017

Luteolin induces apoptosis in BE colorectal cancer cells by downregulating calpain, UHRF1, and DNMT1 expressions.

Luteolin induces apoptosis in BE colorectal cancer cells by downregulating calpain, UHRF1, and DNMT1 expressions.

Journal: Nutrition and cancer

Published: September 11, 2014

Limoniastrum guyonianum aqueous gall extract induces apoptosis in colorectal cancer cells by inhibiting calpain activity.

Limoniastrum guyonianum aqueous gall extract induces apoptosis in colorectal cancer cells by inhibiting calpain activity.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: April 01, 2014

P2Y2 receptor inhibits EGF-induced MAPK pathway to stabilise keratinocyte hemidesmosomes.

P2Y2 receptor inhibits EGF-induced MAPK pathway to stabilise keratinocyte hemidesmosomes.

Journal: Journal of cell science

Published: June 22, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026